936250-20-3,
3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole,
3-Methyl-1H-pyrazole-4-boronic acid pinacol ester,
5-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole,
3-METHYLPYRAZOLE-4-BORONIC ACID, PINACOL ESTER,
3-METHYL-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-1H-PYRAZOLE,
1430754-36-1,
3-METHYL-4-PYRAZOLE BORONIC ACID PINACOL ESTER,
3-Methylpyrazole-4-boronic acid pinacol ester,
3-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole,
AK-38125,
5-METHYLPYRAZOLE-4-BORONIC ACID, PINACOL ESTER,
MFCD08690235,
SCHEMBL140519,
CTK5H2732,
DTXSID50590401,
MSJAEFFWTBMIKT-UHFFFAOYSA-N,
BM407,
ZXBA000337,
BCP21842,
KS-000003RE,
ZX-RL004182,
ANW-64159,
BBL102010,
SBB093972,
STL555809,
AKOS015960133,
AKOS016015841,
ZINC169743765,
CM-1922,
CS-W005192,
FCH1685590,
GS-5719,
OR43573,
PB12557,
AN-26205,
BC000668,
SC-29082,
SY014616,
AB0009866,
AX8165598,
methylpyrazole-4-boronic acid pinacol ester,
TC-152904,
4CH-009078,
ST24028584,
MFCD08690235 (97%),
3-methyl-pyrazole-4-boronic acid pinacol ester,
B-4544,
250M203,
J-512926,
I14-57325,
3-Methyl-1H-pyrazole-4-boronic acid pinacol ester, 97%,
5-methyl-1h-pyrazole-4-boronic acid, pinacol ester 96%,
1H-Pyrazole,3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-,
(3-METHYL-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER,
3-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-pyrazole,
4,4,5,5-tetramethyl-2-(3-methylpyrazol-4-yl)-1,3,2-dioxaborolane,
3-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);-1H-pyrazole,
5-methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole,
1H-PYRAZOLE, 3-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-,
C10H17BN2O2,
ACN-032489,
3-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole, 97% - 250MG 250mg,